AusPAR: Sarilumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Sarilumab (rch) [PDF, 1.12 MB]

AusPAR: Sarilumab (rch) [Word, 1.51 MB]

Attachment: Extract from Clinical Evaluation Report: Sarilumab (rch) [PDF, 3.25 MB]

Attachment: Extract from Clinical Evaluation Report: Sarilumab (rch) [Word, 6.84 MB]

Device/Product Name

Kevzara, Ilsidex

Active ingredients

Sarilumab (rch)

AusPAR Date

30 May 2018

Published

20 July 2018

Submission Number

PM-2015-04024-1-3

Submission Type

New biological entity

Decision

Withdrawn